We hope you enjoy this excerpt from Litigation Daily, the exclusive source for sharp commentary on mega court battles, winning strategies and the issues that obsess elite litigators. Law.com subscribers can sign up for The AmLaw Litigation Daily newsletter here. Anyone else can click here to subscribe.

Our Litigators of the Week are Mike Morin and David Frazier of Latham & Watkins and William (Bill) Raich of Finnegan, Henderson, Farabow, Garrett & Dunner. They led a trial team that helped Sarepta Therapeutics emerge victorious as the counter-claimant in patent litigation against Nippon Shinyaku concerning treatment for Duchenne Muscular Dystrophy, a degenerative muscular disorder. After a one-week timed trial in Delaware federal court, jurors sided with Sarepta, finding the Nippon Shinyaku invalid, finding Sarepta’s patent valid and infringed and awarded Sarepta $115.2 million in damages.